Sephience Powder
Product Images NDC 60468-006

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sephience (NDC 60468-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allphamed Pharbil Arzneimittel Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box (Box)

Sephience 1000 mg oral powder packet, containing sepiapterin. The front label shows the brand name, generic name, dosage strength, and instructions to see enclosed instructions for use. The back label states the product is manufactured for PTC Therapeutics, Inc., including their logo, and has space for lot number and expiration date. The package is a single unit-dose packet.*

FDA Label Image

Inner Label0 (Inner Label0)

Label for Sephience (sepiapterin) oral powder, 1,000 mg per packet. The label states the dosage form as oral powder and instructs to see enclosed directions for use, recommending intake with food. The product is packaged as single unit-dose packets. The label indicates manufacturing for PTC Therapeutics, Inc. with their logo and includes spaces for Lot and Expiration dates.*

FDA Label Image

Inner Label2 (Inner Label2)

Sephience (sepiapterin) Oral Powder, 250 mg per packet, human prescription drug for oral use. The label shows directions to see enclosed instructions and to take with food. The product is packaged in 1 unit-dose packet format. The label indicates manufacturing for PTC Therapeutics, Inc., with associated barcodes and spaces for lot and expiration date.*

FDA Label Image

Outer Label0 (Outer Label0)

Packaging label for Sephience oral powder, 1,000 mg per packet, containing sepiapterin as the active ingredient. The label includes dosing instructions, storage conditions, and manufacturer details. The product is in unit-dose packets, with 30 packets per container, by PTC Therapeutics. The UPC barcode and NDC 52856-301-03 are visible.*

FDA Label Image

Outer Label2 (Outer Label2)

Box packaging label for Sephience (sepiapterin) oral powder 250 mg per packet by PTC Therapeutics. The box contains 30 unit-dose packets, is marked Rx only, and includes storage instructions and directions to take with food. NDC 52856-201-03 is shown on the label.*

FDA Label Image

Chemical Structure (Sephience 01)

Chemical structure of sepiapterin, the active ingredient in Sephience oral powder. The diagram shows a bicyclic structure with amino and hydroxyl functional groups attached, characteristic of sepiapterin's molecular formula.*

FDA Label Image

Figure 1 (Sephience 02)

A line graph comparing mean blood phenylalanine (Phe) levels (µmol/L) over time between placebo and Sephience (sepiapterin) groups. The x-axis shows study phases and weeks (Open-label P1 Baseline to P2 Week 5-6), and the y-axis represents the Phe concentration from 0 to 1250 µmol/L. Sephience shows a marked decrease in mean blood Phe levels over time, while placebo levels remain relatively stable.*

FDA Label Image

250mg Dose Packet (Sephience 03)

Sephience (sepiapterin) Oral Powder 250 mg per packet in a box of 30 unit-dose packets. The packaging features the product name, active ingredient, strength, dosage form, and labeler allphamed Pharbil Arzneimittel GmbH, with instructions to see enclosed directions for use.*

FDA Label Image

1000mg Dose Packet (Sephience 04)

Sephience (sepiapterin) Oral Powder 1,000 mg per packet in a box containing 30 unit-dose packets. The label shows dosage form as oral powder, strength as 1,000 mg per packet, and includes directions to see enclosed instructions. Labeler is allphamed Pharbil Arzneimittel GmbH.*

FDA Label Image

Figure A (Sephience 05)

An instructional illustration labeled 'Figure A' showing items included and not included with Sephience oral powder packets. Included is a depiction of the Sephience oral powder packets. Not included are drawings of an oral dosing syringe, scissors, a container for mixing, a cup labeled 'water or apple juice,' and a small spoon.*

FDA Label Image

Figure B (Sephience 06)

An instructional illustration labeled 'Figure B' depicting a hand pouring Sephience 250 mg powder sachet into a clear container for mixing. The container is graduated with measurement lines showing liquid volume for preparation of oral dosage.*

FDA Label Image

Figure C (Sephience 07)

An instructional illustration showing three labeled items: an oral dosing syringe with labeled parts tip, barrel, and plunger; a container containing powder labeled as container for mixing; and a cup filled with liquid labeled as water or apple juice cup.*

FDA Label Image

Figure D (Sephience 08)

An instructional illustration showing a hand stirring a liquid in a container labeled "container for mixing" using a spoon. The hand holds the spoon and moves it in a circular motion to mix the contents.*

FDA Label Image

Figure E (Sephience 09)

Instructional illustration showing a hand holding a syringe being withdrawn from a container labeled for mixing. The figure is labeled as Figure E and depicts part of a preparation or administration process.*

FDA Label Image

Figure F (Sephience 10)

An instructional black and white line drawing labeled 'Figure F' showing a hand holding a device with a marked scale and a pointed tip, accompanied by an eye symbol indicating visual inspection of the tip area.*

FDA Label Image

Figure G (Sephience 11)

Instructional diagram labeled Figure G demonstrating oral administration of medication using a syringe positioned at a child's mouth, illustrating the method of delivering Sephience (SEPIAPTERIN) oral powder for humans.*

FDA Label Image

Figure A1 (Sephience 12)

Instructional diagram titled 'Figure A' showing items included and not included with Sephience oral powder packets. Included is an image of the Sephience powder packet. Not included are a tablespoon, scissors, container for mixing, water or apple juice, applesauce or strawberry jam cup, and a water or apple juice cup for rinsing.*

FDA Label Image

250mg Foil (Sephience 13)

Sephience (sepiapterin) oral powder packaging label showing a strength of 1,000 mg per packet. The label includes directions to see enclosed instructions for use and administration with food. The product is a 1 unit-dose packet labeled by allphamed Pharbil Arzneimittel GmbH, with an NDC of 52856-301-01.*

FDA Label Image

1000mg Foil (Sephience 14)

Sephience (sepiapterin) oral powder 250 mg per packet packaging label. The label includes the product name, generic name, strength, dosage form, and instructions to see enclosed directions, use for administration into drinking water, and take with food. It also states 1 unit-dose packet with a blue and white color scheme. The labeler is allphamed Pharbil Arzneimittel GmbH.*

FDA Label Image

Figure B1 (Sephience 15)

An instructional illustration labeled Figure B showing a hand pouring Sephience powder from a packet labeled 1000 mg into a container marked for mixing. The powder is depicted falling from the packet into the container below.*

FDA Label Image

Figure C1 (Sephience 16)

An instructional diagram labeled 'Figure C' showing a tablespoon, a container for mixing powder, and two types of cups labeled as 'applesauce or strawberry jam cup' and 'water or apple juice cup.' It visually guides mixing or measuring instructions for oral powder use.*

FDA Label Image

Figure D1 (Sephience 17)

An instructional diagram labeled Figure D shows a hand stirring a mixture inside a transparent container using a spoon. The container is marked as a 'container for mixing', indicating preparation steps for the product Sephience (Sepiapterin) oral powder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.